Johnson & Johnson said its prostate cancer drug Erleada, when used with hormone-blocking therapy before and after prostate ...

Patients were nine times more likely to have little to no cancer remaining in the prostate after surgery, with a 20% reduction in the risk of developing metastasis ...

What you need to know: 8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone. Johnson & Johnson's JNJ.N prostate cancer drug Erleada used with hormone-blocking ...

Despite contributing to half of all conception hurdles, male-factor infertility is rarely talked about. For former AFL player ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

May 31 (Reuters) - Johnson & Johnson's (JNJ.N) ​prostate cancer drug Erleada used with hormone-blocking therapy six months ...

Testosterone treatment significantly reduces mortality among men with Klinefelter syndrome. Researcher calls for changes in guidelines to ensure more patients receive the necessary treatment. More ...

Experts say that switching from tampons to menstrual cups or discs may reduce cramping, fatigue, and bloating.

There is a new name and understanding of a health condition affecting many women. Roughly 10% to 13% of women around the ...

Living Local 15 host Jessica Williams is joined by Justin Humphries, a Franchise Owner of Gameday Men’s Health, as they highlight how Gameday helps men discuss their health, including low ...

Conservatives have long argued they want to end transition care for minors, but federal policies have increasingly limited ...